{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T07:40:03Z","timestamp":1746085203151,"version":"3.40.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.coph.2013.11.012","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T09:45:20Z","timestamp":1387359920000},"page":"74-80","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Experiments with cocaine and heroin addicts\u2014are they predictive?"],"prefix":"10.1016","volume":"14","author":[{"given":"Alan","family":"Bye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2013.11.012_bib0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1741-7015-9-119","article-title":"Novel pharmacotherapeutic treatments for cocaine addiction","volume":"9","author":"Shorter","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.coph.2013.11.012_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.54.1.1","article-title":"Neurobiology of relapse to heroin and cocaine seeking: a review","volume":"54","author":"Shalev","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.coph.2013.11.012_bib0015","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nn1578","article-title":"Is there a common molecular pathway for addiction","volume":"8","author":"Nestler","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2013.11.012_bib0020","first-page":"573","article-title":"Pharmacologic approaches to the treatment of cocaine dependence","volume":"152","author":"Taylor","year":"1990","journal-title":"Western J Med"},{"key":"10.1016\/j.coph.2013.11.012_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jsat.2005.12.007","article-title":"A 12-year follow-up of a treated cocaine-dependent sample","volume":"30","author":"Hser","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.coph.2013.11.012_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2004.07.019","article-title":"The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies","volume":"47","author":"Volkow","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2013.11.012_bib0035","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2013.11.012_bib0040","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI60390","article-title":"Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics","volume":"122","author":"Jeanne Kreek","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coph.2013.11.012_bib0045","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1176\/appi.ajp.160.6.1041","article-title":"Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability","volume":"160","author":"Andrew Chambers","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2013.11.012_bib0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cercor\/10.3.318","article-title":"Addiction: a disease of compulsion and drive: a disease of the orbitofrontal cortex","volume":"10","author":"Volkow","year":"2000","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.coph.2013.11.012_bib0055","doi-asserted-by":"crossref","first-page":"a011940","DOI":"10.1101\/cshperspect.a011940","article-title":"Responses to novelty and vulnerability to cocaine addiction: contribution of a multi-symptomatic animal model","volume":"2","author":"Belin","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coph.2013.11.012_bib0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.coph.2013.11.012_bib0065","doi-asserted-by":"crossref","first-page":"10652","DOI":"10.1523\/JNEUROSCI.3179-04.2004","article-title":"Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex","volume":"24","author":"Trantham-Davidson","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2013.11.012_bib0070","doi-asserted-by":"crossref","first-page":"e61245","DOI":"10.1371\/journal.pone.0061245","article-title":"Cocaine inhibits dopamine D2 receptor signaling via sigma1 D2 receptor heteromers","volume":"8","author":"Navarro","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coph.2013.11.012_bib0075","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1176\/appi.ajp.162.8.1473","article-title":"PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation","volume":"162","author":"Nader","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2013.11.012_bib0080","doi-asserted-by":"crossref","DOI":"10.15695\/vurj.v2i0.2751","article-title":"Effect of prenatal cocaine exposure on D2 receptors and DAT in Rhesus Macaques","volume":"2","author":"Pryweller","year":"2006","journal-title":"Vanderbilt Undergraduate Res J"},{"key":"10.1016\/j.coph.2013.11.012_bib0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1021223113233","article-title":"Risky business: emotion, decision-making, and addiction","volume":"19","author":"Bechara","year":"2003","journal-title":"J Gambling Stud"},{"key":"10.1016\/j.coph.2013.11.012_bib0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.npp.1301420","article-title":"Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys","volume":"33","author":"Banks","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2013.11.012_bib0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1369-1600.2008.00138.x","article-title":"Norepinephrine and stimulant addiction","volume":"14","author":"Sofuoglu","year":"2009","journal-title":"Addict Biol"},{"key":"10.1016\/j.coph.2013.11.012_bib0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/15504260802628767","article-title":"Atomoxetine treatment for cocaine abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): a preliminary open trial","volume":"5","author":"Levin","year":"2009","journal-title":"J Dual Diagn"},{"key":"10.1016\/j.coph.2013.11.012_bib0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuroimage.2009.11.077","article-title":"Acute effect of the anti-addiction drug bupropion on extracellular dopamineconcentrations in the human striatum: an [11C]raclopride PET study","volume":"50","author":"Egerton","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.coph.2013.11.012_sbref0110","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1176\/ajp.156.9.1440","article-title":"Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels","volume":"156","author":"Volkow","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2013.11.012_bib0115","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nn.2862","article-title":"Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors","volume":"14","author":"Bello","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2013.11.012_bib0120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0924-977X(02)00104-9","article-title":"Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies","volume":"12","author":"Volkow","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.coph.2013.11.012_bib0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/scitranslmed.3003062","article-title":"Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine","volume":"3","author":"Levine","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2013.11.012_bib0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.2009.05149.x","article-title":"Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders","volume":"1187","author":"Heidbreder","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.coph.2013.11.012_bib0135","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cct.2012.05.003","article-title":"Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world","volume":"33","author":"Winhusen","year":"2012","journal-title":"J Contemporary Clinical Trials"},{"key":"10.1016\/j.coph.2013.11.012_bib0140","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/jpet.110.167619","article-title":"Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys","volume":"334","author":"Achat-Mendes","year":"2010","journal-title":"J Pharmacol Exper Ther"},{"key":"10.1016\/j.coph.2013.11.012_bib0145","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1523\/JNEUROSCI.1443-08.2008","article-title":"Sleep deprivation decreases binding of [11C]raclopride to dopamine D2\/D3 receptors in the human brain","volume":"28","author":"Volkow","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2013.11.012_bib0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.coph.2013.11.012_bib0155","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/sleep\/27.6.1181","article-title":"What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications","volume":"27","author":"Boutrel","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.coph.2013.11.012_bib0160","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1523\/JNEUROSCI.5221-08.2009","article-title":"Cue-induced dopamine release predicts cocaine preference: positron emission tomography studies in freely moving rodents","volume":"29","author":"Schiffer","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2013.11.012_bib0165","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1073\/pnas.0631749100","article-title":"Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine","volume":"100","author":"Hikida","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.coph.2013.11.012_bib0170","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/sj.npp.1301585","article-title":"The role of acetylcholine in cocaine addiction","volume":"33","author":"Williams","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2013.11.012_sbref0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/alcalc\/agl003","article-title":"Disulfiram, cocaine, and alcohol: two outcomes for the price of one?","volume":"41","author":"Gossop","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.coph.2013.11.012_bib0180","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.alcohol.2007.08.006","article-title":"Central reinforcing effects of ethanol are blocked by catalase inhibition","volume":"41","author":"Edward Nizhnikov","year":"2007","journal-title":"Alcohol"},{"key":"10.1016\/j.coph.2013.11.012_bib0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2005.01.049","article-title":"Inhibition of acetaldehyde metabolism decreases acetylcholine release in medial frontal cortex of freely moving rats","volume":"1039","author":"Jamal","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.coph.2013.11.012_bib0190","first-page":"1","article-title":"Ethanol and acetaldehyde exposure induces specific epigenetic modifications in the prodynorphin gene promoter in a human neuroblastoma cell line","volume":"25","author":"D\u2019Addario","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.coph.2013.11.012_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/aapsj070371","article-title":"Kappa opioid antagonists: past successes and future prospects","volume":"7","author":"Metcalf","year":"2005","journal-title":"AAPS J"},{"key":"10.1016\/j.coph.2013.11.012_bib0200","doi-asserted-by":"crossref","DOI":"10.1208\/aapsj070361","article-title":"k opioids as potential treatments for stimulant dependence","volume":"7","author":"Prisinzano","year":"2005","journal-title":"AAPS"},{"key":"10.1016\/j.coph.2013.11.012_sbref0205","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/npp.2008.165","article-title":"The dynorphin\/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders?","volume":"34","author":"Shippenberg","year":"2009","journal-title":"Neuropsychopharmacol Rev"},{"key":"10.1016\/j.coph.2013.11.012_bib0210","doi-asserted-by":"crossref","unstructured":"Trifilieff P, Martinez D: Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence www.frontiersin.org 4 Article 44 (2013).","DOI":"10.3389\/fpsyt.2013.00044"},{"key":"10.1016\/j.coph.2013.11.012_bib0215","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1208\/s12248-011-9296-3","article-title":"Quantitative PK\u2013PD model-based translational pharmacology of a novel kappa opioid receptor antagonist between rats and humans","volume":"13","author":"Chang","year":"2011","journal-title":"AAPS J"},{"key":"10.1016\/j.coph.2013.11.012_sbref0220","doi-asserted-by":"crossref","first-page":"146ra110","DOI":"10.1126\/scitranslmed.3003948","article-title":"A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence","volume":"4","author":"Wee","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2013.11.012_sbref0225","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/0269881106060835","article-title":"Naltrexone and buprenorphine combination in the treatment of opioid dependence","volume":"20","author":"Gerra","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.coph.2013.11.012_sbref0230","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","article-title":"k-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.coph.2013.11.012_bib0235","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pharmthera.2009.05.008","article-title":"Kappa-opioid ligands in the study and treatment of mood disorders","volume":"23","author":"Carlezon","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2013.11.012_bib0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2007.09.019","article-title":"Effects of gabapentin on cocaine self-administration, cocaine triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats","volume":"97","author":"Penga","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.coph.2013.11.012_bib0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/syn.10278","article-title":"Treating cocaine addiction: from preclinical to clinical trial experience with -vinyl GABA","author":"Brodie","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.coph.2013.11.012_sbref0250","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/npp.2010.226","article-title":"Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans","volume":"36","author":"Amen","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2013.11.012_bib0255","first-page":"101","article-title":"Treating cocaine dependency with psychopharmacotherapy and behavioral therapy","volume":"1","author":"Liebman","year":"2010","journal-title":"e-Research"},{"key":"10.1016\/j.coph.2013.11.012_bib0260","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874473711003010049","article-title":"Review of treatment for cocaine dependence","volume":"3","author":"Penberthy","year":"2010","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.coph.2013.11.012_bib0265","unstructured":"Borg L, Kravets I, Jeanne Kreek M, The pharmacology of long-acting as contrasted with short-acting opioids in principles of addiction medicine, edn 4th. Edited by Feillin DA. Chapter 9, 117\u2013132."},{"key":"10.1016\/j.coph.2013.11.012_bib0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1300\/J069v26n01_07","article-title":"Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study","volume":"26","author":"Hser","year":"2007","journal-title":"J Addict Dis"},{"key":"10.1016\/j.coph.2013.11.012_bib0275","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1124\/jpet.104.072686","article-title":"Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: clinical and preclinical studies","volume":"312","author":"Melichar","year":"2005","journal-title":"JPET"},{"key":"10.1016\/j.coph.2013.11.012_bib0280","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.2007.07121944","article-title":"Divided doses for methadone maintenance","volume":"165","author":"Adinoff","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2013.11.012_bib0285","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0022-3565(24)39007-X","article-title":"Opioid receptor imaging with positron emission tomography and [18F]cyclofoxy in long-term, methadone-treated former heroin addicts","volume":"295","author":"Kling","year":"2000","journal-title":"JPET"},{"key":"10.1016\/j.coph.2013.11.012_bib0290","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bbr.2008.10.013","article-title":"NMDA receptor antagonism in the ventral tegmental area impairs acquisition of reward-related learning","volume":"197","author":"Zellnera","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.coph.2013.11.012_bib0295","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI60390","article-title":"Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics","volume":"122","author":"Zhou","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coph.2013.11.012_bib0300","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1176\/appi.ajp.160.6.1041","article-title":"Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability","volume":"160","author":"Chambers","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2013.11.012_bib0305","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cercor\/10.3.318","article-title":"Addiction: a disease of compulsion and drive: a disease of the orbitofrontal cortex","volume":"10","author":"Volkow","year":"2000","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.coph.2013.11.012_bib0310","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archgenpsychiatry.2012.1a","article-title":"Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence","volume":"69","author":"Kreek","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.coph.2013.11.012_sbref0315","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopsych.2006.04.043","article-title":"Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices","volume":"61","author":"Greenwald","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.coph.2013.11.012_bib0320","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-Acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"J Psychiatry Neurosci"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489213002300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489213002300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T07:10:54Z","timestamp":1746083454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489213002300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":64,"alternative-id":["S1471489213002300"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2013.11.012","relation":{},"ISSN":["1471-4892"],"issn-type":[{"type":"print","value":"1471-4892"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}